|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endocrine Regulation of Energy Metabolism by the Skeleton显示文摘 | Na Kyung Lee Hideaki Sowa Eiichi Hinoi Mathieu Ferron Jong Deok Ahn Cyrille Confavreux Romain Dacquin Patrick J. Mee Marc D. McKee Dae Young Jung Zhiyou Zhang Jason K. Kim Franck Mauvais-Jarvis Patricia Ducy Gerard Karsenty | 2007 | Cell2007，，3： | 5 |
| 2 | Deep infiltrating endometriosis is a determinant factor of cumulative pregnancy rate after intracytoplasmic sperm injection/in vitro fertilization cycles in patients with endometriomas显示文摘 | Marcos Ballester Anne Oppenheimer Emmanuelle Mathieu d’Argent Cyril Touboul Jean-Marie Antoine Michelle Nisolle Emile Dara? | 2012 | Fertility and Sterility2012，，2： | 1 |
| 3 | Endocrine Regulation of Energy Metabolism by the Skeleton显示文摘 | Na Kyung Lee Hideaki Sowa Eiichi Hinoi Mathieu Ferron Jong Deok Ahn Cyrille Confavreux Romain Dacquin Patrick J. Mee Marc D. McKee Dae Young Jung Zhiyou Zhang Jason K. Kim Franck Mauvais-Jarvis Patricia Ducy Gerard Karsenty | 2007 | Cell2007，，3： | 1 |
| 4 | Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma显示文摘Pancreatic ductal adenocarcinoma(PDAC) is expected to become the second leading cause of death from cancer by 2030. Despite intensive research in the field of therapeutics, the 5-year overall survival is approximately 8%, with only 20% of patients eligible for surgery at the time of diagnosis. The tumoral microenvironment(TME) of the PDAC is one of the main causes for resistance to antitumoral treatments due to the presence of tumor vasculature, stroma, and a modified immune response. The TME of PDAC is characterized by high stiffness due to fibrosis, with hypo microvascular perfusion, along with an immunosuppressive environment that constitutes a barrier to effective antitumoral treatment. While systemic therapies often produce severe side effects that can alter patients’ quality of life, locoregional therapies have gained attention since their action is localized to the pancreas and can thus alleviate some of the barriers to effective antitumoral treatment due to their physical effects. Local hyperthermia using radiofrequency ablation and radiation therapy-most commonly using a local high single dose-are the two main modalities holding promise for clinical efficacy. Recently, irreversible electroporation and focused ultrasound-derived cavitation have gained increasing attention. To date, most of the data are limited to preclinical studies, but ongoing clinical trials may help better define the role of these locoregional therapies in the management of PDAC patients. | Thomas Lambin Cyril Lafon Robert Andrew Drainville Mathieu Pioche Frédéric Prat | 2022 | World Journal of Gastroenterology2022，28，13： | 1 |
| 5 | Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis显示文摘 | Oury Franck Ferron Mathieu Huizhen Wang Confavreux Cyrille Xu Lin Lacombe Julie Srinivas Prashanth Chamouni Alexandre Lugani Francesca Lejeune Herve Kumar T Rajendra Plotton Ingrid Karsenty Gerard | 2013 | Journal of Clinical Investigation2013，，6： | 1 |
| 6 | MP联合沙利度胺、MP和低强度自体干细胞移植治疗老年多发性骨髓瘤(IFM99—06):一项随机试验显示文摘背景对于老年人多发性骨髓瘤,马法兰与泼尼松联合化疗方案(MP)目前仍被认为是标准治疗方案。本试验旨在评价在MP方案的基础上联用沙利度胺或低强度的自体干细胞移植能否提高患者的存活率。
方法从2000年5月22日到2005年8月8日,共招募447例初治多发性骨髓瘤患者,年龄65~75岁,随机接受MP方案(n=196)、MP联合沙利度胺方案(MPT,n=125)或低强度(马法兰,100mg/m^2)的自体干细胞移植方案(MEL100,n=126)。主要终点为总体存活率。采用意向治疗分析。本试验已在ClinicalTrials.gov注册,注册号为NCT00367185。
结果中位随访51.5个月(IQR34.4~63.2),中位总体存活时间:MP组为33.2个月(13.8~54.8),MPT组为51.6个月(26.6~未到达),MELl00组为38.3个月(13.0~61.6)。在中位总体存活率方面,MPT方案优于MP方案(HR0.59,95%C10.46~0.81:P=0.0006)或MEL100方案(HR0.69,95%C10.49~0.96;P=0.027)。而MEL100方案和MP方案无差异(HR0.86,95%C10.65~1.15;P=0.32)。
结论试验结果提示,MPT方案目前应作为老年多发性骨髓瘤初治的推荐方案。 | Thierry Facon Jean Yves Mary Cyrille Hulin Lotfi Benboubker Michel Attal Brigitte Pegourie Marc Renaud Jean Luc Harou-sseau Gaelle Guillerm Carine Chaleteix Mamoun Dib Laurent Voillat Herve Maisonneuve Jacques Troncy Veronique Dorv-aux Mathieu Monconduit Claude Martin Philippe Casassus Jerome Jaubert Henry Jardel Chantal Doyen Brigitte Kolb Bruno Anglaret Bernard Grosbois Ibrahim Yakoub-Agha Claire Mathiot Herve Avet-Loiseau 王鸿鹄(译) | 2008 | 世界临床医学2008，2，1： | 0 |
| 7 | Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo显示文摘Despite the availability of an effective measles virus(MeV)vaccine and efforts to increase vaccine coverage by the WHO,UNICEF,and their partners,MeV has not been eradicated,and the estimated global measles death rose from 89,780 in 2016 to 207,500 in 2019.1 Because there is an effective measles vaccine,antiviral development for measles has not been prioritized,but recent outbreaks have highlighted the need for drugs to prevent transmission in unvaccinated populations and to protect and treat immunocompromised individuals.We identified several neutralizing mouse monoclonal antibodies(mAbs)that target the MeV fusion(F)protein in its prefusion state2 and inhibit fusion and viral infection.We engineered a single-chain variable fragment(scFv)from the most potent anti-MeV F mAb.The scFv retains the ability to inhibit fusion and prevents infection in vitro,and intranasal administration of the scFv antibody construct prevents infection in vivo. | Cyrille Mathieu Marion Ferren Olivia Harder Francesca TBovier Tara CMarcink Camilla Predella Fabrizio Angius Jennifer Drew-Bear NValerio Dorrello Alex LGreninger Anne Moscona Stefan Niewiesk Branka Horvat Matteo Porotto | 2021 | Cellular & Molecular Immunology2021，18，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员